Stock 3176 MEDIGEN BIOTECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Medigen Biotechnology Corp.

Equities

3176

TW0003176004

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
42.9 TWD +0.59% Intraday chart for Medigen Biotechnology Corp. +2.14% -4.24%
Mar. 29 The Ministry of Health and Welfare Approves Collaborative Autologous Gamma-Delta T Cell Therapy Project by Medigen Biotechnology Corp. and Chi Mei Hospital CI
Mar. 26 Taiwan MOHW Approves A New Version of the Collaborative Autologous Natural Killer Cell Therapy Project by Medigen Biotechnology Corp. and Changhua Christian Hospital CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
The Ministry of Health and Welfare Approves Collaborative Autologous Gamma-Delta T Cell Therapy Project by Medigen Biotechnology Corp. and Chi Mei Hospital
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Medigen Biotechnology Corp. Announces Appointment of Chieh-Liang Lin as Chief Scientific Officer
Medigen Biotechnology Corp. Applies to the Taiwan Food and Drug Administration for Phase I/Ii Clinical Trial Ofallogeneic Natural Killer Cells (Magicell-NK)
Medigen Biotechnology Corp. Announces That the Ministry of Health and Welfare Has Approved the Collaborative Autologous Gamma-Delta T Cell Therapy Project by the Company and Changhua Christian Hospital
Medigen Biotechnology Corp. Announces Signing of the Sales Cooperation Agreement for the New Drug OBP-301 in Japan
The Ministry of Health and Welfare Approves the Collaborative Autologous Gamma-Deltat Cell Therapy Project by Medigen Biotechnology Corp.And Taichung Tzu Chi Hospital
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3176 Stock
  4. News Medigen Biotechnology Corp.
  5. Other languages